A Single-center, Randomized, Two Part, Open-label, Crossover Study to Assess the Relative Bioavailability and Food Effect of New Formulations of GSK2248761 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2010
At a glance
- Drugs Fosdevirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 30 Mar 2010 Actual patient number (24) added as reported by ClinicalTrials.gov.
- 30 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.